BCL2L11 and glioblastoma: In glioblastoma, m5C modifications of mature miR-181a-5p lead to the loss of its ability to target the mRNA of the pro-apoptotic protein BIM, also known as B-cell chronic lymphocytic leukemia/lymphoma (Bcl-2)-like 11 (BCL2L11) [106].